stockrowLisata Therapeutics, Inc. (LSTA) vs Palatin Technologies, Inc. (PTN)
- Lisata Therapeutics, Inc. LSTA 1.01 −4.72%
- Palatin Technologies, Inc. PTN 5.74 −4.65%
Lisata Therapeutics, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and Palatin Technologies, Inc. are of similar size ($10.7M and $10.2M). Lisata Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −24.7%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lisata Therapeutics, Inc. leads on 8 and Palatin Technologies, Inc. on 8.
Valuation
Profitability
| Metric | LSTA | PTN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.49% | 100.00% | 65.16% |
| Operating margin | 0.00% | (65.74%) | 0.00% |
| Net margin | 0.00% | (63.54%) | 0.00% |
| Free cash flow margin | 0.00% | (103.07%) | 0.00% |
| Return on equity | (101.66%) | (877.60%) | (50.12%) |
| Return on assets | (80.81%) | (142.11%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack